Search Within

Cindy J Lee

Formats
  1. Journal Article (13)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (18)
  2. GSK Faculty (18)
  3. Genitourinary Oncology Service (18)
  4. Human Oncology and Pathogenesis Program (18)
  5. Solid Tumor Oncology Division (18)
  6. Sloan Kettering Institute Postdocs (17)

More Groups

People
  1. Yu Chen (18)
  2. Ping Chi (13)
  3. Mohini Pachai (8)
  4. Sarah Warda (8)
  5. Juan Yan (7)
  6. Wai Pung Wong (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (10)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Cancer Research (4)
  3. Science (2)
  4. Cancer Discovery (1)
  5. Journal of Clinical Investigation (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. American Association for the Advancement of Science (2)
  3. Nature Publishing Group (2)
  4. Amer Assoc Advancement Science (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PRC2-inactivating mutations in cancer enhance cytotoxic response to DNMT1-targeted therapy via enhanced viral mimicry
    Journal Article

    Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; Bayshtok, G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
    Journal Article

    Tang, F.; Xu, D.; Wang, S.; Wong, C. K.; Martinez-Fundichely, A.; Lee, C. J.; Cohen, S.; Park, J.; Hill, C. E.; Eng, K.; more...
    Science (2022)

    Fulltext@MSK | Save
  • Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors
    Journal Article

    Chi, P.; Qin, L.; Camacho, N.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor
    Journal Article

    Chi, P.; Qin, L. X.; Nguyen, B.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
    Journal Article

    Mao, N.; Zhang, Z.; Lee, Y. S.; Choi, D.; Agudelo Rivera, A.; Li, D.; Lee, C.; Haywood, S.; Chen, X.; Chang, Q.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Combined inhibition of Gα(q) and MEK enhances therapeutic efficacy in uveal melanoma
    Journal Article

    Hitchman, T. D.; Bayshtok, G.; Ceraudo, E.; Moore, A. R.; Lee, C.; Jia, R.; Wang, N.; Pachai, M. R.; Shoushtari, A. N.; Francis, J. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Chromatin accessibility landscape and transcriptome of castration resistant prostate cancers reveals novel subtypes and diverse master regulators
    Meeting Abstract

    Tang, F.; Wong, C. K.; Cohen, S.; Lee, C.; Liu, M.; Bareja, R.; Eng, K.; Beg, S.; Puca, L.; Sternberg, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Aberrant expression of ERG promotes resistance to combined PI3K and AR pathway inhibition through maintenance of AR target genes
    Journal Article

    Mao, N.; Gao, D.; Hu, W.; Hieronymus, H.; Wang, S.; Lee, Y. S.; Lee, C.; Choi, D.; Gopalan, A.; Chen, Y.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save